IP: Rafael Simó Canonge
Col·laboradors: Marina Jimenez Iglesias, Cristina Hernández Pascual, Jaume Rigo Quera, Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of d, Queralt Martin Saladich, Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of d, Alejandro López Targa, Patricia Bogdanov Baruj, Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of d, Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of d, Andreea Ciudin Mihai, Ferran Casals Riera
Entitat finançadora: EUROPEAN COMMISSION
Finançament: 950410
Referència: RECOGNISED_H2020SC1BHC2019
Durada: 01/01/2020 - 31/12/2024

IP: SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH..
Col·laboradors: Marc Miquel Moltó Abad, Olga Sánchez- Maroto Carrizo, Julia German Cortes, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH.., Belen Garcia Prats, Angels Alcina Mila, Alejandro López Targa, Maria Fidel Lledò, Fernanda Raquel Da Silva Andrade, Diana Fernandes de Rafael, Simon Schwartz Navarro
Entitat finançadora: EUROPEAN COMMISSION
Finançament: 649580
Referència: SAFE-N-MEDTECHEC_H2020-NMBP2018
Durada: 01/04/2019 - 30/09/2023

IP: Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholi
Col·laboradors: Alejandro López Targa, Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholi
Entitat finançadora: EUROPEAN COMMISSION
Finançament: 93750
Referència: CARBALIVE_H2020-PHC2014
Durada: 01/05/2015 - 31/01/2021